Literature DB >> 34586557

From Molecular Pathology of COVID 19 to Nigella Sativum as a Treatment Option: Scientific Based Evidence of Its Myth or Reality.

Muhammad Atif1, Farrah Naz2, Junaid Akhtar3,4, Muhammad Imran6, Sidrah Saleem3, Javed Akram5, Muhammad Imran6, Muhammad Ikram Ullah1.   

Abstract

COVID-19 virus is a causative agent of viral pandemic in human beings which specifically targets respiratory system of humans and causes viral pneumonia. This unusual viral pneumonia is rapidly spreading to all parts of the world, currently affecting about 105 million people with 2.3 million deaths. Current review described history, genomic characteristics, replication, and pathogenesis of COVID-19 with special emphasis on Nigella sativum (N. sativum) as a treatment option. N. sativum seeds are historically and religiously used over the centuries, both for prevention and treatment of different diseases. This review summarizes the potential role of N. sativum seeds against COVID-19 infection at levels of in silico, cell lines and animal models.
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  COVID-19; Nigella sativum; coronavirus; nCoV-19; review

Mesh:

Year:  2021        PMID: 34586557      PMCID: PMC8479716          DOI: 10.1007/s11655-021-3311-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


Appendix
  77 in total

Review 1.  Molecular mechanisms of TRP regulation in tumor growth and metastasis.

Authors:  Dimitra Gkika; Natalia Prevarskaya
Journal:  Biochim Biophys Acta       Date:  2008-12-06

Review 2.  Immunomodulatory and therapeutic properties of the Nigella sativa L. seed.

Authors:  Mohamed Labib Salem
Journal:  Int Immunopharmacol       Date:  2005-07-01       Impact factor: 4.932

3.  Current Drugs with Potential for Treatment of COVID-19: A Literature Review.

Authors: 
Journal:  J Pharm Pharm Sci       Date:  2020       Impact factor: 2.327

Review 4.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

5.  Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin.

Authors:  Toshio Morikawa; Fengming Xu; Kiyofumi Ninomiya; Hisashi Matsuda; Masayuki Yoshikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-04       Impact factor: 1.645

6.  Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa.

Authors:  Zulfiqar Ali; Daneel Ferreira; Paulo Carvalho; Mitchell A Avery; Ikhlas A Khan
Journal:  J Nat Prod       Date:  2008-05-10       Impact factor: 4.050

7.  Chemical composition and medicinal properties of Nigella sativa Linn.

Authors:  M A Khan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

Review 8.  A review on therapeutic potential of Nigella sativa: A miracle herb.

Authors:  Aftab Ahmad; Asif Husain; Mohd Mujeeb; Shah Alam Khan; Abul Kalam Najmi; Nasir Ali Siddique; Zoheir A Damanhouri; Firoz Anwar
Journal:  Asian Pac J Trop Biomed       Date:  2013-05

9.  The effect of Nigella sativa extract on tracheal responsiveness and lung inflammation in ovalbumin-sensitized guinea pigs.

Authors:  Mohammad Hossein Boskabady; Rana Keyhanmanesh; Saeed Khamneh; Mohammad Ali Ebrahimi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.

Authors:  Jia-Bo Wang; Zhong-Xia Wang; Jing Jing; Peng Zhao; Jing-Hui Dong; Yong-Feng Zhou; Guang Yang; Ming Niu; Xu Zhao; Tian-Jun Jiang; Jing-Feng Bi; Zhe Xu; Ping Zhang; Dan Wu; Zhao-Fang Bai; Yu-Ming Guo; Si-Miao Yu; Yong-Qiang Sun; Zi-Teng Zhang; Xiao-Yan Zhan; Peng-Yan Li; Jin-Biao Ding; Peng-Fei Zhao; Xue-Ai Song; Jian-Yuan Tang; Dong-Chu He; Zhu Chen; En-Qiang Qin; Rui-Lin Wang; Xiao-He Xiao
Journal:  Chin J Integr Med       Date:  2020-07-16       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.